MARIETTA, Georgia., May 30, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound health care and an emerging therapeutic biologics firm, announced recently that typically the Company's board associated with directors (the "Board") has adopted a new comprehensive plan to refresh the make up with the Board. The particular plan was developed by simply the Board within cooperation with one of the Company's largest investors, Prescience Point Capital Management LLC ("Prescience Point"), and uses the completion associated with the Audit Committee's independent investigation into alleged wrongdoing simply by the prior elderly management team plus the engagement of BDO USA, LLP as the Provider's new independent authorized public accounting organization. Underneath the plan, 6 new directors, like MiMedx's new CEO, Timothy R. Wright, would be added to the Board. As a result, Category II and School III of the particular Board would comprise entirely of new directors after the Industry’s 2019 annual meeting of shareholders. Typically https://www.mixcloud.com/bergerhutchison9/ involves the appointment of three of Supposition Point's nominees, including M. Kathleen Behrens Wilsey, Ph. D. as the innovative Chairwoman of typically the Board, along with E. Todd Newton, which is expected in order to become the Chairman of the Audit Committee after the Company's 2019 annual meeting of shareholders. "The MiMedx Board plus the current senior management team have already been working tirelessly to be able to address the fallout from the actions of the prior senior management crew and get the Company back on course, " said Charles R. Evans, Chairman regarding the Board. "Now that we include made substantial improvement on these methodologies, it is time to begin the particular Board transition and even refreshment process. We are pleased to be able to been employed by collaboratively together with Prescience Point to be able to identify through adding new directors who bring exceptional experience plus track records to MiMedx. Using the Exam Committee's investigation full and an intend to recharge the Board in place, the Company is actually in a new position to focus on future and even enhance its enterprise, for the good thing about all stakeholders. inches "We welcome the great plan to invigorate the Board, plus we anticipate MiMedx's future under brand new leadership. Were pleased that our assistance has resulted within a reconstituted Table, with the help of six fresh directors with dear industry experience, interactions and reputational funds, " said Eiad Asbahi, Founder in addition to Managing Partner involving Prescience Point. "We used MiMedx because we expect the Company has immense potential as a chief in advanced wound care and beneficial biologics. We believe MiMedx is in the path to unlock substantial aktionär value and secure a thriving foreseeable future for the Company. " Within the refreshment strategy, Prescience Point nominee M. https://www.cheaperseeker.com/u/thuesenmercer6 , Ph. M. is going to be appointed or nominated for political election for the Board and is likely to end up being named the modern Chairwoman of the Plank. Dr. Behrens Wilsey is currently typically the Chairwoman of Sarepta Therapeutics, Inc. (SRPT), a multi-billion-dollar health-related research and medication development company targeted on the finding and development associated with unique RNA-targeted therapeutics for your treatment of rare neuromuscular conditions. Dr. Behrens Wilsey previously served in the boards regarding Amylin Pharmaceuticals, Incorporation. (formerly AMLN) and even Abgenix, Inc. (formerly ABGX). In improvement to Doctor Behrens Wilsey, the Panel will also find, or nominate intended for election to typically the Board, Richard M. Barry, James M. Bierman, K. Jake Newton, Mr. Wright and another movie director that will be employed from the Company and even Prescience Point. https://peatix.com/user/15908965 of typically the anticipated new company directors appear at the final of this push release. The business wants to file it is preliminary proxy materials for its 2018 Annual Meeting today. The Board stimulates shareholders to wait to receive the Company's proxy materials along with the Company's BLUE web proxy card before voting. Sidley Austin LLP is acting as legal advisor to be able to MiMedx. Olshan Frome Wolosky LLP is certainly acting as legal advisor to Prescience Point. About Richard J. Barry Mr. Barry has served as a director of Elcelyx Therapeutics, Inc., an exclusive pharmaceutical company, considering that February 2013 and even has served like a Managing Member associated with GSM Fund, LLC, a fund established to the sole objective of buying Elcelyx Therapeutics, since February 2013. Earlier inside his career, he was a founding person in Eastbourne Capital Administration LLC, a large equity hedge account buying a variety associated with industries, including health care, and dished up as the Managing General Partner and Portfolio Manager through 1999 to it is close in the new year. Prior to that will, he was a Portfolio Manager and Managing Director involving Robertson Stephens Expense Management, an purchase company, from 1995 until 1999. Just before that, Mr. Craig spent over tough luck years in several functions in institutional value and investment administration firms, including Lazard Freres, Legg Builder and Merrill Lynch. Mr. Barry features served being an overseer of Sarepta Therapeutics, Inc. (SRPT), a new genetic medicine company, since June 2015, and he is a huge Partner and Admonitory Board member associated with the San Diego Padres since 2009. Mr. Barry previously served as a movie director of Cluster Wi-fi, LLC, a software organization, from 2011 till 2014, along with BlackLight Power, Inc. (n/k/a Brilliant Light Power, Inc. ), an energy research company, from 2009 right up until 2010. Mr. Barry holds a B. A. from Missouri State University. Regarding M. Kathleen Behrens Wilsey, Ph. M. Dr. Behrens Wilsey served as a new member from the plank of directors of each of Sarepta Therapeutics, Inc. (SRPT), a multi-billion dollars medical research in addition to drug development company focused on the breakthrough discovery and development associated with unique RNA-targeted therapeutics for the remedying of rare neuromuscular diseases, since March this year (Chairwoman of the particular Board since 04 2015) and IGM Biosciences, Inc., a private biotechnology company, given that January 2019. Dr . Behrens Wilsey worked as an self-employed life sciences advisor and investor due to the fact December 2009. The lady served as the Co-Founder, President, Main Executive Officer in addition to as an overseer of the KEW Group Inc., a personal oncology services firm, from January this year until June 2014. Earlier in the woman career, Dr. Behrens Wilsey served as a general partner with regard to selected venture funds for RS Investments, a mutual account firm, from mil novecentos e noventa e seis until December year. While Dr. Behrens Wilsey worked in RS Investments, by 1996 to 2002, she served as being a managing director with the firm and, through 2003 to January 2009, she served as a specialist to the firm. In the course of that time, Medical professional. Behrens Wilsey likewise served as a member associated with the President's Council of Advisors on Science and Technological innovation (PCAST), from 2001 to 2009 so that as chairwoman of PCAST's Subcommittee on Individualized Medicine, as properly as the Leader, director and chairwoman of the National Venture Capital Association, the organization that advocates for public insurance plan that supports the American Entrepreneurial environment, from 1993 until 2000. Just before that will, she served as a general spouse and managing movie director for Robertson Stephens & Co., an investment company, from 1983 through 1996. The lady served as some sort of director of Amylin Pharmaceuticals, Inc. (formerly AMLN), a biopharmaceutical company, from yr before the company's sale this year to Bristol-Myers Squibb Co. Previous to that, your woman served on the table of directors Abgenix, Inc. (formerly ABGX), a biopharmaceutical company, from 2001 till the company has been sold to Amgen, Inc. in 06\. From 1997 to 2005, Doctor Behrens was a representative of the Panel on Science, Technology and Economic Insurance plan for the National Study Council. Dr. Behrens Wilsey was in addition a Co-Founder associated with the Coalition with regard to 21st Century Medication, a trade connection achievable generation diagnostics companies. Dr. Behrens Wilsey holds some sort of B. S. inside Biology and the Ph. D. inside Microbiology from the College or university of California, Davis. About James M. Bierman Mr. Bierman served as Chief executive and Ceo regarding Owens & Minor, Inc., a Fortune five hundred company along with a primary distributor of healthcare and surgical products, from September 2014 to June 2015. Previously, he offered in various some other senior roles from Owens & Minor, including President in addition to Chief Operating Expert from August 2013 to September 2014, Executive Vice Chief executive and Chief Functioning Officer from Drive 2012 to August 2013, Executive Bassesse President and Primary Financial Officer by April 2011 in order to March 2012, and even Senior Vice Chief executive and Chief Economic Officer from June 2007 to The spring 2011. From i b?rjan p? tv?tusentalet to 2004, Mister. Bierman served like Executive Vice President and Chief Monetary Officer at Quintiles Transnational Corp. Prior to joining Quintiles Transnational, Mr. Bierman was a partner at Arthur Andersen LLP. Mr. Bierman currently serves upon the board regarding directors of Tenet Healthcare Corporation (THC) and previously offered on the planks of directors regarding Owens & Slight, Inc. (OMI) in addition to Team Health Holdings, Inc. (formerly TMH). Mr. Bierman earned his B. A. from Dickinson University and his Michael. B. A. in Cornell University's Manley Graduate School of Management. About T. Todd Newton Mister. Newton has, due to the fact 2014, served because Ceo and the member of the board of directors of Apollo Endosurgery, Inc. (APEN), a leader in the industry of gastrointestinal healing endoscopy. From 2009 to 2014, Mr. Newton served seeing that Executive Vice Us president and Chief Economic Officer at ArthroCare Corporation (ARTC), a new medical device company, including from 2013 as Chief Working Officer. Prior to his leadership at ArthroCare, Mr. Newton served in a number of professional officer roles, including President and Key Executive Officer, with Synenco Energy, Inc., a Canadian oil sands company. Through 1994 to 2004, Mr. Newton was a Partner in Deloitte & Patte LLP. Mr. Newton holds a B. B. A. inside accounting in the University of Texas with San Antonio. Concerning Timothy R. Wright Mr. Wright grew to be MiMedx's Chief Executive Officer, successful as of May possibly 13, 2019. Formerly, Mr. Wright served as a Partner at Signal Hillside Advisors, LLC, a new consulting practice, since February 2011. Mr. Wright served like President and Key Executive Officer of M2Gen Corp., a new privately held cancers and health informatics company, between Come july 1st 2017 and The month of september 2018. Prior in order to M2Gen Corp., Mister. Wright served like Executive Vice President, Mergers and Acquisitions, Technique and Innovation intended for Teva Pharmaceutical Industries Ltd. ("Teva"), some sort of pharmaceutical company specializing in generic drugs, from April 2015 until August 2017. Before Teva, Mister. Wright was the founding partner involving The Ohio Point out University Comprehensive Cancer Drug Development Company. Mr. Wright in addition served as Chairman, Interim Chief Executive Officer plus a director regarding Curaxis Pharmaceutical Company ("Curaxis"), a prescription company specializing within the introduction of drugs regarding the take care of Alzheimer's disease and various cancers, from July 2011 to This summer 2012. Curaxis acquired been experiencing economic difficulties prior to be able to Mr. Wright's tenure and, as the result, the firm filed for Phase 11 bankruptcy inside July 2012. Mister. Wright has recently been a director involving Agenus, Inc. (Nasdaq: AGEN), an immune system oncology company, considering that 2006 and their lead director due to the fact 2009. Mr. Wright also serves like Chairperson with the Kentkucky State University Comprehensive Cancer Center Drug Development Institute, functions as director of The Ohio State Innovation Foundation and rests on The Ohio State University School of Pharmacy Dean's Corporate Council. Mister. Wright earned the Bachelor's of Science in Marketing by The Ohio Point out University. About MiMedx MiMedx� is surely an industry leader in sophisticated wound care and even an emerging therapeutic biologics company developing and distributing human being placental tissue allografts with patent-protected procedures for multiple industries of healthcare. The particular Company processes a persons placental tissue using its proprietary PURION� process methodology, among other processes, to create allografts by making use of aseptic processing approaches in addition to fatal sterilization. MiMedx provides supplied over a single. 5 million allografts to date. For added information, please check out www.mimedx.com. About Supposition Point Capital Management Prescience Point Capital Management is some sort of private investment administrator that employs forensic investigative techniques to uncover significant mispricings inside global markets. It specializes in extensive investigations of difficult-to-analyze public companies to be able to uncover significant elements of the business that will have been disregarded or ignored by others. Prescience Point manages private funds on behalf of its clients and even principals and needs positions both lengthy and short found in support of their research. Prescience Level invests across the broad set regarding equities that it believes have extraordinarily large disparities in between what their root web based intrinsically worth and what their stock options cost. The stable opened by entrepreneur Eiad Asbahi in 2009 and is based in Baton Rouge, LA. Prescience Stage Capital Management will be a registered investment decision advisor with typically the State of Louisiana. Follow @PresciencePoint. Safe and sound Harbor Statement This kind of press release includes forward-looking statements, including assertions regarding the plan associated with MiMedx Group, Incorporation. (the "Company") to be able to refresh the Plank, the consequence of such refreshment around the Company in addition to expectations with admiration to Board command. Forward-looking statements may be identified by terms such as "believe, " "expect, inches "may, " "plan, " "potential, very well "will, " "would" and similar expressions and are based on current beliefs and expectations. Forward-looking claims are controlled by hazards and uncertainties, and even the Company engagement investors against putting undue reliance in such statements. Genuine results may change materially from those set forth in the forward-looking statements as a result associated with various factors, including the results of any election involving Class II or even Class III administrators. There is no assurance that the Board's nominees can be elected at the Company's 2018 yearly meeting of shareholders (the "2018 Total annual Meeting") or typically the Company's 2019 gross annual meeting of investors. Any forward-looking claims speak only since of the day of this report, and except while required by regulation, the corporation assumes little obligation to up-date any forward-looking statement, whether as the result of fresh information, future activities or perhaps. Important Data The Company hopes to file the definitive proxy affirmation and associated ORANGE proxy card in connection with the particular solicitation of proxies for the 2018 Annual Meeting together with the Securities plus Exchange Commission (the "SEC"). Details concerning the nominees in the Company's board associated with directors for political election at the 2018 Annual Meeting can be contained in the web proxy statement. BEFORE MAKING ANY KIND OF VOTING DECISION, INVESTORS OF THE COMPANY ARE URGED TO SEE ALL RELEVANT DOCUMENTS FILED WITH OR PERHAPS FURNISHED TO THE SEC, INCLUDING THE PARTICULAR COMPANY'S DEFINITIVE PROXY STATEMENT AND VIRTUALLY ANY SUPPLEMENTS THERETO, DUE TO THE FACT THEY WILL HAVE IMPORTANT INFORMATION. Buyers and shareholders will be able to have a copy regarding the definitive web proxy statement and other files filed from the Business free of cost from the SEC's site at www.sec.gov. Typically the Company's shareholders may also be in a position to obtain, without having charge, a duplicate of the definitive proxy server statement and additional relevant filed papers from the "SEC Filings" section of you can actually website with www.mimedx.com. Participants in the Solicitation The particular Company, its owners, its director candidates and certain from the executive officers usually are participants in the particular solicitation of proxies from shareholders in respect of typically the 2018 Annual Meeting. Information regarding the particular names of the Company's directors, movie director nominees and exec officers and the particular interests inside the Company by security holdings or otherwise is set forth in the particular Company's Current Record on Form 8-K filed with the particular SEC on May 25, 2019. Additional information regarding the interests of these participants in any kind of proxy solicitation in addition to a description of their direct in addition to indirect interests, simply by security holdings or otherwise, will furthermore be incorporated into any proxy statement and other relevant textiles to be filed together with the SEC, if and when that they available.